Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Analgesics

Fighting pain: the structure of gabapentin and its binding site in the Cavα2δ subunit

Gabapentinoids are first-line treatments for chronic pain but are associated with adverse side effects. A cryo-EM structure of gabapentin bound to its interaction site on the calcium channel α2δ subunit now paves the way for the rational design of analgesics with greater selectivity and a reduced potential for adverse effects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Structural insights into interactions between gabapentin and Cavα2δ and its effects on calcium channel trafficking.

References

  1. Field, M. J. et al. Proc. Natl Acad. Sci USA 103, 17537–17542 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Marais, E., Klugbauer, N. & Hofmann, F. Mol. Pharmacol. 59, 1243–1248 (2001).

    Article  CAS  PubMed  Google Scholar 

  3. Davies, A. et al. Proc. Natl Acad. Sci USA 107, 1654–1659 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wu, J. et al. Nature 537, 191–196 (2016).

    Article  CAS  PubMed  Google Scholar 

  5. Nieto-Rostro, M., Ramgoolam, K., Pratt, W. S., Kulik, A. & Dolphin, A. C. Proc. Natl Acad. Sci. USA 115, E12043–E12052 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nieto-Rostro, M., Patel, R., Dickenson, A. H. & Dolphin, A. C. Pain 64, 1264–1279 (2023).

    Article  Google Scholar 

  7. Chen, Z., Mondal, A. & Minor, D. L. Jr. Nat. Struct. Mol. Biol. https://doi.org/10.1038/s41594-023-00951-7 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chen, Z. et al. Nature https://doi.org/10.1038/s41586-023-06175-5 (in the press).

  9. Wang, M., Offord, J., Oxender, D. L. & Su, T. Z. Biochem. J. 342, 313–320 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Gumerov, V. M. et al. Proc. Natl Acad. Sci. USA 119, e2110415119 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Page, K. M., Gumerov, V. M., Dahimene, S., Zhulin, I. B. & Dolphin, A. C. Channels (Austin) 17, 2167563 (2023).

    Article  PubMed  Google Scholar 

  12. Gao, S., Yao, X. & Yan, N. Nature 596, 143–147 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tran-Van-Minh, A. & Dolphin, A. C. J. Neurosci. 30, 12856–12867 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Goodman, C. W. & Brett, A. S. JAMA Intern. Med. 179, 695–701 (2019).

    Article  PubMed  Google Scholar 

  15. Keppel Hesselink, J. M. Int. J. Clin. Pharmacol. 1, 1–3 (2016).

Download references

Acknowledgements

G.W.Z. is supported by research grants from the Natural Sciences and Engineering Research Council of Canada, and the Canadian Institutes of Health Research. G.W.Z. is a Canada Research Chair.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerald W. Zamponi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferron, L., Gandini, M.A. & Zamponi, G.W. Fighting pain: the structure of gabapentin and its binding site in the Cavα2δ subunit. Nat Struct Mol Biol 30, 717–719 (2023). https://doi.org/10.1038/s41594-023-01013-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41594-023-01013-8

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing